Amalgamated Bank Oncternal Therapeutics, Inc. Call Options Transaction History
Amalgamated Bank
- $11.7 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ONCT
# of Institutions
4Shares Held
362KCall Options Held
0Put Options Held
0-
Act Capital Management, LLC Wayne, PA210KShares$1.48 Million0.26% of portfolio
-
Dowling & Yahnke LLC San Diego, CA150KShares$1.06 Million0.06% of portfolio
-
Column Capital Advisors, LLC1.45KShares$10,2220.0% of portfolio
-
Coppell Advisory Solutions LLC Coppell, TX20Shares$1410.0% of portfolio
About Oncternal Therapeutics, Inc.
- Ticker ONCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,517,200
- Market Cap $391M
- Description
- Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...